Rocket Returns: This Madhusudhan Kela and Sunil Singhania-owned smallcap stock has rallied 45% since April QIP

Shilpa Medicare, a stock held by Madhusudhan Kela and Sunil Singhania, has delivered a 45% return since its allotment to these ace investors four months ago in a qualified institutional placement (QIP). Singhania received 6 lakh shares of the drug company through the Abakkus Diversified Alpha Fund-2, while Kela’s joint venture fund, Cohesion MK Best Ideas Sub-Trust, was allotted over 8.79 lakh shares.

Cohesion MK Best Ideas Sub-Trust is a joint venture between Cohesion Investments and Madhusudan Kela.

At the end of the June quarter, Cohesion MK Best held a 2.12% stake in the company, representing 20.76 lakh shares. The BSE shareholding data does not reflect the latest holdings of the Abakkus Diversified Alpha Fund-2, suggesting that Singhania may have either exited the stock or reduced his stake below 1%.

The issue, launched between April 8 and 12, allocated 5% or more of the QIP to 11 funds, including four from ICICI Prudential Mutual Fund and two from Bandhan MF, among others.

Shares were allocated at Rs 455 each, which was a discount of Rs 22.33 per share, or 4.68%, from the floor price of Rs 477.33 per share. From the floor price, the stock has shot up by 62%.Shilpa Medicare’s shares have had an impressive run over the past year, returning 130% compared to the Nifty’s 29% gain.The stock closed at Rs 735 on the NSE on Monday, up Rs 37.20 or 5.33% from Friday’s closing price. The rise followed the company’s announcement that it has successfully completed phase-3 clinical studies of its novel product, SMLNUD07 (Nor Ursodeoxycholic Acid or NorUDCA) tablets. The company expects this product to “revolutionize” the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source link

Denial of responsibility! NewsConcerns is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a Comment